This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Preganglionic sympathetic nerves

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Preganglionic sympathetic nerve fibres have their cell bodies in the intermediolateral horn of spinal segments T1 to L2. Their myelinated axons pass out of the spinal cord by the anterior roots. The anterior root is continuous with a spinal nerve after fusion with the segmental posterior root. The preganglionic sympathetic nerve fibre passes into the spinal nerve and then passes to synapse with the cell bodies of postganglionic sympathetic fibres. The latter exist in either pre- or paravertebral ganglia - see submenu.

A few preganglionic fibres pass directly through the paravertebral ganglia to synapse within the prevertebral ganglia. They form discrete nerves between the ganglia which contain only preganglionic efferent fibres and afferents from assorted viscera. Examples include the splanchnic nerves.

The preganglionic fibres from given spinal levels innervate a certain set of structures - see submenu.

One generalisation about the preganglionic sympathetic neurones is that, compared to preganglionic parasympathetic neurones, they have a relatively short course after leaving the spinal cord before they reach the postganglionic neurone.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.